Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$244.93 - $354.82 $174,390 - $252,631
-712 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$295.56 - $354.83 $210,438 - $252,638
712 New
712 $253,000
Q4 2021

Feb 08, 2022

SELL
$289.48 - $383.27 $169,635 - $224,596
-586 Closed
0 $0
Q3 2021

Oct 20, 2021

SELL
$360.3 - $422.82 $39,993 - $46,933
-111 Reduced 15.93%
586 $225,000
Q2 2021

Aug 13, 2021

BUY
$385.96 - $443.85 $6,947 - $7,989
18 Added 2.65%
697 $284,000
Q1 2021

Apr 19, 2021

SELL
$372.25 - $429.44 $6,700 - $7,729
-18 Reduced 2.58%
679 $281,000
Q4 2020

Jan 19, 2021

BUY
$318.23 - $411.57 $221,806 - $286,864
697 New
697 $287,000

Others Institutions Holding TFX

About TELEFLEX INC


  • Ticker TFX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,906,400
  • Market Cap $8.94B
  • Description
  • Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...
More about TFX
Track This Portfolio

Track Wambolt & Associates, LLC Portfolio

Follow Wambolt & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.